U
Zealand Pharma A/S ZLDPF
$40.99 -$0.01-0.02% OTC PK
Recommendation
Dividend Power Score
Prev Close
--
Volume
Avg Vol (90D)
--
Market Cap
Dividend & Yield
--
52-Week Range
-- - --
P/E (TTM)
--
EPS (TTM)

12/31/2025 09/30/2025 06/30/2025 03/31/2025 12/31/2024
Net Income -59.09M -63.32M 1.15B -47.30M -41.59M
Total Depreciation and Amortization 719.50K 1.13M 944.80K 840.60K 506.80K
Total Amortization of Deferred Charges 3.18M -- -- -- 2.36M
Total Other Non-Cash Items -189.20M 18.46M 157.12M 1.11M -5.57M
Change in Net Operating Assets 81.85M -25.78M -14.23M -25.29M 18.51M
Cash from Operations -162.54M -69.52M 1.30B -70.64M -25.79M
Capital Expenditure -2.63M -570.80K -977.00K -910.40K -168.10K
Sale of Property, Plant, and Equipment -- -- -- -- --
Cash Acquisitions -- -- -- -- --
Divestitures -- -- -3.59M 3.33M --
Other Investing Activities -55.58M -133.43M -234.89M 75.81M 25.48M
Cash from Investing -58.21M -134.00M -239.46M 78.24M 25.32M
Total Debt Issued -- -- -- -- 0.00
Total Debt Repaid -5.98M -5.42M -4.43M -4.34M -4.59M
Issuance of Common Stock 16.62M 1.90M 27.09M 3.55M 81.00K
Repurchase of Common Stock -- -74.76M -332.41M -- 0.00
Issuance of Preferred Stock -- -- -- -- --
Repurchase of Preferred Stock -- -- -- -- --
Total Dividends Paid -- -- -- -- --
Other Financing Activities -- -- -- -- -100.00K
Cash from Financing 1.66M -12.26M -47.12M -111.60K -658.10K
Foreign Exchange rate Adjustments 1.47M 16.63M -25.47M -411.60K 517.30K
Miscellaneous Cash Flow Adjustments -- -- -- -- --
Net Change in Cash -217.61M -199.15M 983.85M 7.07M -616.80K